News and Trends 2 Feb 2023Recurv Pharma receives funding for cancer therapy development Recurv Pharma Inc. is receiving up to $24 million in funding from TVM Capital Life Science through its TVM Life… February 2, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email